31P and 1H Nuclear magnetic resonance spectroscopy of blood plasma in female patients with preeclampsia

International Journal of Biomedical Science

Volumn 8, Issue 4, 2012, Pages 258-263

  Schott, Susanne ^a   Hahn, Josef ^a   Kurbacher, Christian ^a   Moka, Detlef ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

31P and 1H magnetic resonance spectroscopy; Gestosis; Lipid metabolism; Preeclampsia

Indexed keywords

AMINO ACID; FATTY ACID; HIGH DENSITY LIPOPROTEIN; HYDROGEN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; PHOSPHORUS;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD COMPONENT; BLOOD SAMPLING; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PATHOGENESIS; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PLASMA; PREECLAMPSIA; PREGNANCY COMPLICATION; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84871990194     PISSN: 15509702     EISSN: 15552810     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1996; 354 (9181): 810-816.
2. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am. J. Obstet. Gynecol. 1982; 142: 159-167.
3. Vigil-De Gracia P. Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. Int. J. Gynecol. Obstet. 2001; 72: 17-23.
4. Magann EF, Martin JN. Twelve steps to optimal management of HELLP syndrome. Clin. Obstet. Gynecol. 1999; 42: 532-541.
5. Wolf G, Wenzel U, Stahl RAK, Hüneke B. Hypertensive disorders in pregnancy (German). Med. Klin. 2001; 96: 78-86.
6. Donker R, Ásgeirsdóttir SA, Gerbens F, et al. Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro. Reproductive Sciences. 2005; 12: 98-106.
7. Rodie VA, Young A, Jordan F, Sattar N, et al. Human placental peroxisome proliferator-activated receptor d and g expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. Reproductive Sciences. 2005; 12: 320-329.
8. Arriaga-Pizano L, Jimenez-Zamudio L, Vadillo-Ortega F, Martinez-Flores A, et al. The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the choriodecidual and fetal compartments. Reproductive Sciences. 2005; 12: 335-342.
9. Taylor RN. Immunobiology of preeclampsia (review). Am. J. Reprod. Immunol. 1997; 37: 79-86.
10. Garzetti GG, Tranquili AL, Cugini AM, Mazzanti L, et al. Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia. Obstet. Gynecol. 1993; 81: 337-340.
11. Coffey CG. Cellular bases for the lipid-related aspects of preeclampsia. Med. Hypotheses. 2003; 60: 716-719.
12. Podo F, de Certaines JD. Magnetic resonance spectroscopy in cancer: phospholipid, neutral lipid and lipoprotein metabolism and function. Anticancer Res. 1996; 16: 1305-1316.
13. Leibfritz D. An introduction to the potential of 1H-, 31P-and 13C-NMR-spectroscopy. Anticancer Res. 1996; 16: 1317-1324.
14. Laatikainen R, Niemitz M, Malaisse WJ, Biesemans M, et al. A Computational strategy for the deconvolution of NMR spectra with multiplet structures and sonstraints: analysis of overlapping 13C-2H multipletts of 13C enriched metabolites form cell suspensions incubated in deuterated media. Magnet. Reson. Med. 1996; 36: 359-365.
15. Ghio A, Bertolotto A, Resi V, Volpe L, et al. Tirglyceride metabolism in pregnancy. Adv. Clin. Chem. 2011; 55: 133-153.
16. Spickett CM, Reglinski J, Smith WE, Wilson R, et al. Erythrocyte glutathione balance and membrane stability during preeclampsia. Free Radic. Biol. Med. 1998; 24: 1049-1055.
17. Emara SH, EL-Hawary MF, Abdel-Karim HA, El-Heneidy F. Amniotic fluid total lipids, cholesterol, phospholipids and inorganic phosphorus in toxaemia of pregnancy. Acta. Med. Acad. Sci. Hung. 1976; 33: 179-183.
18. Clausen T, Slott M, Solvoll K, Drevon CA, et al. High intake of energy, sucrose and polyunsaturated fatty acids is associated with increased risk of preeclampsia. Am. J. Obstet. Gynecol. 2001; 185: 451-458.
19. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am. J. Obstet. Gynecol. Epub ahead of print (2006).
20. Feinberg BB. Preeclampsia: the death of Goliath. Am. J. Reprod. Immunol. 2006; 33: 84-98.